A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ … (NCT06747117) | Clinical Trial Compass
RecruitingNot Applicable
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigoâ„¢ Aspiration System (STRIDE II)
United States300 participantsStarted 2025-05-18
Plain-language summary
The primary objective of this study is to collect and evaluate clinical evidence supporting the safety and performance of the Indigoâ„¢ Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥18 years
* Patients with a confirmed diagnosis of lower limb arterial occlusion located in the common iliac or below, with a minimum of 2 cm of proximal patency in the common iliac
* Acute occlusion with symptom duration of 14 days or less at presentation
* ALI Rutherford Category I, IIa or IIb
* First-line treatment with the Indigo Aspiration System using Computer Assisted Vacuum Thrombectomy (CAVT) aspiration tubing
* Informed consent is obtained from either patient or legally authorized representative (LAR) per Institutional Review Board/Ethics Committee requirements
* Previously enrolled patients presenting with a new acute occlusion in the contralateral limb meeting all eligibility criteria may be re-enrolled if the new acute occlusion is greater than 30 days from the initial index procedure
Exclusion Criteria:
* Life expectancy \<1 year
* Target vessel size \<2 mm
* Target thrombus is in the aorta or isolated profunda artery
* Prior major amputation (proximal to the tarsometatarsal joint) in the target limb
* Prior minor amputation in the target limb within the past 6 months that is not completely healed or cannot bear weight
* LE ALI secondary to dissection, vasculitis, or target vessel trauma, including iatrogenic etiology from treatment of a proximal location in the target limb, and non-thrombotic material such as tumor fragments, fat emboli, septic emboli, and foreign bodies
* Target thrombus in a vein bypass graft, previously revised b…